Dendrimer scaffold for the amplification of in vivo pretargeting ligations Journal Article


Authors: Cook, B. E.; Membreno, R.; Zeglis, B. M.
Article Title: Dendrimer scaffold for the amplification of in vivo pretargeting ligations
Abstract: The development of immunoconjugates requires a careful balance between preserving the functionality of the antibody and modifying the immunoglobulin with the desired cargo. Herein, we describe the synthesis, development, and in vivo evaluation of a novel bifunctional dendrimeric scaffold and its application in pretargeted PET imaging. The site-specific modification of the huA33 antibody with this dendrimeric scaffold yields an immunoconjugate-(ss)huA33-DEN-TCO-decorated with similar to 8 trans-cyclooctene (TCO) moieties, a marked increase compared to the similar to 2 TCO/mAb of a nondendrimeric control immunoconjugate ((ss)huA33-PEG(12)-TCO). Pretargeted PET imaging and biodistribution experiments were used to compare the in vivo performance of these two immunoconjugates in athymic nude mice bearing subcutaneous SW1222 human colorectal cancer xenografts. To this end, the mice were administered 100 mu g of each immunoconjugate followed 120 h later by the injection of a tetrazine-bearing radioligand, [Cu-64]Cu-SarAr-Tz. Pretargeting with (ss)huA33-DEN-TCO produced excellent tumoral uptake at 24 h (8.9 +/- 1.9 %ID/g), more than double that created by (ss)huA33-PEG(12)-TCO (4.1 +/- 1.3 %ID/g). Critically-and somewhat surprisingly-the attachment of the G(0.5) dendrimeric structures did not hamper the in vivo behavior of the immunoconjugate, suggesting that this versatile bifunctional scaffold may have applications beyond pretargeting.
Keywords: immunoreactivity; radioimmunotherapy; optimization; conjugation; monoclonal-antibody; strategy; in-111; alder click chemistry; metal-chelating polymers; c-11-labeled tetrazine
Journal Title: Bioconjugate Chemistry
Volume: 29
Issue: 8
ISSN: 1043-1802
Publisher: American Chemical Society  
Date Published: 2018-08-15
Start Page: 2734
End Page: 2740
Language: English
ACCESSION: WOS:000442185500025
DOI: 10.1021/acs.bioconjchem.8b00385
PROVIDER: wos
PUBMED: 29969558
PMCID: PMC6432625
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Zeglis
    118 Zeglis
  2. Brendon Ellery Cook
    8 Cook